Spero Therapeutics Inc (SPRO)
1.23
-0.08
(-6.11%)
USD |
NASDAQ |
Nov 14, 13:04
Spero Therapeutics Shareholders Equity (Quarterly): 80.50M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 80.50M |
March 31, 2024 | 96.25M |
December 31, 2023 | 106.89M |
September 30, 2023 | 53.70M |
June 30, 2023 | 54.78M |
March 31, 2023 | 64.84M |
December 31, 2022 | 75.93M |
September 30, 2022 | 32.48M |
June 30, 2022 | 35.92M |
March 31, 2022 | 62.47M |
December 31, 2021 | 88.29M |
September 30, 2021 | 111.90M |
June 30, 2021 | 90.25M |
March 31, 2021 | 118.85M |
December 31, 2020 | 132.04M |
Date | Value |
---|---|
September 30, 2020 | 132.79M |
June 30, 2020 | 73.71M |
March 31, 2020 | 82.43M |
December 31, 2019 | 74.57M |
September 30, 2019 | 92.68M |
June 30, 2019 | 109.31M |
March 31, 2019 | 112.97M |
December 31, 2018 | 115.50M |
September 30, 2018 | 125.20M |
June 30, 2018 | 65.31M |
March 31, 2018 | 74.54M |
December 31, 2017 | 84.60M |
September 30, 2017 | 23.92M |
June 30, 2017 | 31.78M |
December 31, 2016 | 10.17M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
32.48M
Minimum
Sep 2022
132.79M
Maximum
Sep 2020
82.56M
Average
80.50M
Median
Jun 2024
Shareholders Equity (Quarterly) Benchmarks
Arbutus Biopharma Corp | 106.89M |
Equillium Inc | 22.43M |
NovaBay Pharmaceuticals Inc | -0.617M |
Palatin Technologies Inc | -0.1115M |
iBio Inc | 21.32M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 149.88M |
Total Liabilities (Quarterly) | 69.38M |
Current Ratio | 2.678 |